Results 21 to 30 of about 18,399 (161)

Prevention of Postoperative Nausea and Vomiting in Early Recovery: A Comparative Study of Ondansetron and Metoclopramide in Adults Undergoing Elective Lower Abdominal Surgery

open access: yesAUIQ Complementary Biological System
Postoperative nausea and vomiting (PONV) remain common complications following surgery, despite the availability of various prophylactic antiemetic agents. This study aimed to compare the effectiveness of ondansetron and metoclopramide in preventing PONV
Majid Fakhir Al-Hamaidah   +6 more
doaj   +1 more source

Analysis of Dietary Intake during Consecutive-Day Chemotherapy for Bone and Soft-Tissue Sarcomas

open access: yesFrontiers in Nutrition, 2018
BackgroundBone and soft tissue sarcomas are commonly treated with consecutive-day chemotherapy regimens consisting of multiple anticancer agents. Chemotherapy-induced nausea and vomiting (CINV) is a serious adverse effect of these regimens and may result
Yuta Hori   +7 more
doaj   +1 more source

Outcomes of Patients with Aortic Diseases Treated by Antiemetic Drug, Who Were Transported by a Physician-staffed Helicopter in Japan

open access: yesJournal of Emergencies, Trauma and Shock
Introduction: Aortic diseases have been observed to manifest the symptoms such as nausea and vomiting. We conducted a retrospective investigation to ascertain the clinical significance of antiemetic drug use for patients with aortic diseases transported ...
Youichi Yanagawa   +7 more
doaj   +1 more source

The epidemiology and phenomenology of non-antipsychotic-induced dystonia: a hybrid systematic-narrative review

open access: yesEuropean Psychiatry
Background Medication-induced dystonia (MID) is a movement disorder (MD), characterized by involuntary sustained or intermittent muscle contractions, causing abnormal, often repetitive, movements, postures, or both.
Kirsten Catthoor   +2 more
doaj   +1 more source

Asenapine versus olanzapine for the treatment of nausea and vomiting in patients with cancer: A retrospective study

open access: yesNeuropsychopharmacology Reports
Aim Patients with cancer often experience nausea and vomiting (N/V), but may have difficulty using olanzapine (OLZ), a common antiemetic. Asenapine (ASE) is a multi‐acting receptor‐targeted antipsychotic like OLZ, although there is little evidence that ...
Tomohiko Kimura   +5 more
doaj   +1 more source

Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation

open access: yesClinical Hematology International, 2022
Hematopoietic stem cell transplantation (HSCT) is an integral part of the treatment strategy in patients with a hematological disorder. Chemotherapy-induced nausea and vomiting (CINV) is still an issue in patients who undergo HSCT.
Sayako Yuda   +3 more
doaj   +1 more source

How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literature

open access: yesClinical Parkinsonism & Related Disorders, 2023
Introduction: Pretreatment with the antiemetic trimethobenzamide has been recommended practice in the United States (US) to address the risk of nausea and vomiting during initiation of apomorphine treatment.
Stuart H. Isaacson   +3 more
doaj   +1 more source

Adherence to guidelines on prophylaxis of chemotherapy-induced nausea and vomiting in the National Cancer Institute, Sudan

open access: yesSouth African Journal of Oncology, 2017
Objective: To evaluate the adherence to American Society of Clinical Oncology (ASCO) guidelines for antiemetic prophylaxis of chemotherapy-induced nausea and vomiting and assess the outcomes of the prescribed antiemetic drugs. Methods: This prospective,
Moawia M.A. Elhassan   +2 more
doaj   +1 more source

Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson’s Disease: Is the Prophylactic Use of an Antiemetic Necessary?

open access: yesJournal of Parkinson’s Disease, 2023
Background: Nausea is common upon initiating dopamine agonists in patients with Parkinson’s disease (PD); however, pretreatment with an antiemetic is recommended only when initiating apomorphine formulations. Objective: Evaluate the need for prophylactic
Robert A. Hauser   +7 more
doaj   +1 more source

The prophylactic antiemetic therapies in management of differentiated thyroid cancer patients with radioactive iodine therapy: a single-center, non-randomized clinical trial

open access: yesFrontiers in Endocrinology
ObjectiveThe present study was to investigate three different single-drug regimens to show which was more effective to reduce radioactive iodine therapy (RAI) associated nausea and vomiting, and to compare the occurrence of long-term gastrointestinal ...
Xiao Li   +7 more
doaj   +1 more source

Home - About - Disclaimer - Privacy